Related Experiment Video
Updated: Jun 23, 2026

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
Published on: October 10, 2025
[Clostridium difficile as a potential pathogen in preterm neonates]
Iva Vágnerová1, Ivana Kohnová, Jan Saitz
1Department of Microbiology, Palacký University in Olomouc, Czech Republic. vagneri@fnol.cz
Insights
Clostridium difficile toxins A and B were detected in hospitalized patients with antibiotic-associated diarrhea. The study also investigated the role of these toxins in neonates, comparing toxin detection with C. difficile cultures.
Area of Science:
- Medical Microbiology
- Gastroenterology
- Neonatology
Background:
- Antibiotic therapy can disrupt gut microbiota, increasing the risk of Clostridium difficile infection (CDI).
- CDI manifests as diarrhea and other abdominal symptoms, particularly in hospitalized patients.
- The role of C. difficile toxins in neonatal conditions like necrotizing enterocolitis warrants investigation.
Purpose of the Study:
- To detect Clostridium difficile toxins A and B in hospitalized patients with antibiotic-associated diarrhea.
- To evaluate the potential involvement of these toxins in neonatal gastrointestinal issues, alongside intestinal immaturity.
- To correlate toxin detection with C. difficile culture results in stool samples.
Main Methods:
- Stool samples were collected from hospitalized patients experiencing diarrhea or abdominal symptoms linked to antibiotic use.
- Toxin A and B detection assays were performed on stool samples.
- C. difficile cultures were conducted on selected samples for comparison with toxin detection.
Main Results:
- Clostridium difficile toxins A and B were detected in the stool samples of symptomatic patients.
- Toxin detection was also performed in neonates, including those without gastrointestinal symptoms.
- Comparison between toxin detection and C. difficile culture results was conducted.
Conclusions:
- Clostridium difficile toxins are present in hospitalized patients with antibiotic-associated gastrointestinal symptoms.
- Further investigation is needed to fully elucidate the role of C. difficile toxins in neonatal conditions.
- Toxin detection assays provide a method for diagnosing CDI and can be correlated with microbiological cultures.
Objective:
To detect the presence of Clostridium difficile toxins A and B in the stools of patients hospitalized in the University Hospital Olomouc who developed diarrhoea or other abdominal symptoms (abdominal pain, tympanites, indigestion, partial intestinal obstruction) related to antibiotic therapy. Given occasional dyspepsia and necrotizing enterocolitis in preterm neonates, to consider the potential role of these toxins, in addition to that of the immature intestine, in the development of the condition. To confirm the hypothesis by stool tests to detect the toxins also in normal neonates or those with no gastrointestinal symptoms. In selected stool samples, to compare detection of the toxins with C. difficile strains confirmed by culture.
Related Concept Videos
Development of the Oral Microbiota
Development of Human Microbiota
Microbiota Modulation by Antibiotics
Bacterial Gastroenteritis
Botulism
Dysbiosis of the Gut Microbiota

